2) γ-glutamylcysteine synthetase
γ-谷氨酰半胱氨酸合酶
1.
Objective To explore the mechanism of traditional Chinese medicine(TCM) treatment according to syndrome differentiation in treating chronic obstructive pulmonary disease(COPD) by observing the changes of nuclear factor-κB(NF-κB) and γ-glutamylcysteine synthetase(γ-GCS) expression levels in rats.
目的通过观察慢性阻塞性肺疾病(COPD)大鼠核因子κB和γ-谷氨酰半胱氨酸合酶(γ-GCS)水平的变化,探讨中医药治疗COPD的机理。
2.
Objective To explore the regulation of peroxisome proliferator-activated receptor γ coactivator 1α(PGC-1α) and NF-E2-related factor 2(Nrf2) on expression of γ-glutamylcysteine synthetase(γ-GCS),and their roles in chronic obstructive pulmonary disease(COPD).
目的探讨过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α)和红系衍生的核因子相关因子2(Nrf2)对γ-谷氨酰半胱氨酸合酶(γ-GCS)表达的调控及其在COPD中的作用和意义。
3) γ-glutamyl cysteine synthetase(γ-GCS)
γ-谷氨酰半胱氨酸甘氨酸合成酶
5) γ-glutamylcysteine synthetase
γ-谷氨酰胺半胱氨酸合成酶
1.
The effects of ambroxol hydrochloride on transforming growth factor-β_1 and γ-glutamylcysteine synthetase in lung of smoking rats;
盐酸氨溴索对吸烟大鼠肺内转化生长因子-β_1和γ-谷氨酰胺半胱氨酸合成酶表达的影响
6) γ-glutamylcysteine synthetase
γ-谷氨酰半胱氨酸合成酶
1.
Cloning and Hyperxpression of γ-glutamylcysteine synthetase from Saccharomyce cerevisiae;
酵母γ-谷氨酰半胱氨酸合成酶基因的克隆与原核高效表达
2.
The activity of γ-glutamylcysteine synthetase was showed by the content of inorganic phosphate formed in the re.
方法在体外实验中,以鼠红细胞裂解液为反应体系,分别检测对照组和低、高剂量同型半胱氨酸处理后反应体系中生成的无机磷酸和谷胱甘肽含量,以生成的无机磷酸的mmol数表示γ-谷氨酰半胱氨酸合成酶的活性。
3.
Objective To explore the influence of inhaled glucocorticosteroid on γ-glutamylcysteine synthetase(γ-GCS) in inflammatory cell of sputum in children with asthma.
目的探讨吸入糖皮质激素对哮喘患儿痰炎性细胞γ-谷氨酰半胱氨酸合成酶(γ-GCS)的影响。
补充资料:5-L-谷氨酰-L-半胱氨酰甘氨酸
分子式:C10H17N3O6S
分子量:307.32
CAS号:70-18-8
性质:熔点182-192°C。比旋光度-16.5° (c=2, H2O)。水溶性soluble。
分子量:307.32
CAS号:70-18-8
性质:熔点182-192°C。比旋光度-16.5° (c=2, H2O)。水溶性soluble。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条